| Literature DB >> 32535613 |
Haoran Qi1,2, Jingcai Xue1,2, Junying Gao3, Yun Zhang4, Jianmin Sun2, Guodong Wang2.
Abstract
BACKGROUND The incidence of osteoporotic vertebral fractures (OVCFs) has increased significantly in recent years. In order to assess osteoporotic fracture healing process, it is necessary to study the characteristics after this type of vertebral fracture. However, there are few researches on fracture healing process in severe OVCFs. We aim to investigate the histological healing process and the kinetics of bone turnover markers following severe OVCFs. MATERIAL AND METHODS There were 149 patients with severe OVCFs included in this study. Fasting blood samples were obtained to detect bone turnover markers levels. A transpedicular bone biopsy was performed to collect bone biopsy specimens during vertebroplasty surgery. Stratification of healing process was performed: stage I (1-3 days), stage II (4-10 days), stage III (11-20 days), stage IV (21-30 days), stage V (1-3 months), stage VI (3-6 months). RESULTS Quantitative analysis of bone histomorphometry showed that a large amount of necrotic bone tissue was observed in stage VI (12.92±3.66%). Bone turnover markers showed the concentration of ß-isomerized C-terminal telopeptide (ß-CTX) which reflects activity in osteoclast continued to increase in stage VI (0.9±0.33 ng/mL). These results differed from previous reports of other type vertebral fractures. CONCLUSIONS Bone histomorphometric analysis and bone turnover markers showed that severe osteoporotic vertebral compression fractures often associated with delayed union and nonunion during the healing process.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32535613 PMCID: PMC7313424 DOI: 10.12659/MSM.923713
Source DB: PubMed Journal: Med Sci Monit ISSN: 1234-1010
Figure 1Diagram of location and operation channel for obtaining bone tissue sample.
Figure 2(A–F) Pictures of tissues observed under the light microscopy during severe OVCFs healing process: (A) cancellous bone (BV); (B) fibrous tissue (FV); (C) woven bone (WBV); (D) necrotic bone (NBV); (E) endochondral bone (EBV); (F) lamellar bone structure (LBV).
Figure 3(A–F) Histomorphometric analysis of fracture healing at different stages after severe OVCFs. A large amount of necrotic bone and fibrous tissue still appeared after more than 1 month of fractures. Cancellous bone volume/tissue volume (BV/TV%), fibrous tissue volume/tissue volume (FV/TV%), endochondral bone volume/tissue volume (EBV/TV%), necrotic bone volume/tissue volume (NBV/TV%), woven bone volume/tissue volume (WBV/TV%), and lamellar bone volume/tissue volume (LBV/TV%) are indicated as mean±standard error of mean (SEM).
Fracture callus morphometry in patients with severe OVCFs classified according to fracture staging.
| Variable | Stage I | Stage II | Stage III | Stage IV | Stage V | Stage VI | P |
|---|---|---|---|---|---|---|---|
| BV/TV (%) | 16.33±2.69 | 13.01±3.98 | 11.96±3.09 | 12.93±3.05 | 13.89±3.63 | 15.52±3.87 | 0.001 |
| FV/TV (%) | 15.06±7.01 | 21.92±11.05 | 23.6±10.22 | 21.89±7.36 | 21.5±7.01 | 7.63±3.86 | <0.001 |
| EBV/TV (%) | 0 | 0 | 10.71±3.97 | 9.51±3.36 | 2.61±0.97 | 2.78±1.39 | <0.001 |
| NBV/TV (%) | 5.13±2.61 | 10.21±5.22 | 8.21±2.33 | 11.3±3.05 | 7.32±2.72 | 12.92±3.66 | <0.001 |
| WBV/TV (%) | 0 | 0 | 0 | 20.39±1.98 | 17.71±6.49 | 3.22±1.68 | <0.001 |
| LBV/TV (%) | 0 | 0 | 0 | 0 | 15.45±3.43 | 14.96±5.07 | <0.001 |
Cancellous bone volume/tissue volume (BV/TV%), fibrous tissue volume/tissue volume (FV/TV%), endochondral bone volume/tissue volume (EBV/TV%), necrotic bone volume/tissue volume (NBV/TV%), woven bone volume/tissue volume (WBV/TV%), and lamellar bone volume/tissue volume (LBV/TV%). All values are expressed as mean±standard deviation (SD).
Figure 4(A–F) Concentrations of bone turnover markers at different stages after severe OVCFs. Levels of bone resorption markers and bone formation markers were still significantly higher than normal levels at the late stage of fracture. Concentrations of N-terminal propeptide of type I collagen (PINP), β-isomerized C-terminal telopeptide (β-CTX), alkaline phosphatase (ALP), calcium, phosphorus, and osteocalcin are expressed by mean±standard error of mean (SEM).
Bone turnover markers in patients with severe OVCFs classified according to fracture staging.
| Variable | Stage I | Stage II | Stage III | Stage IV | Stage V | Stage VI | P |
|---|---|---|---|---|---|---|---|
| Calcium (mmol/L) | 2.23±0.15 | 2.25±0.09 | 2.21±0.13 | 2.22±0.11 | 2.2±0.15 | 2.25±0.3 | 0.971 |
| Phosphorus (mmol/L) | 1.11±0.23 | 1.23±0.18 | 1.21±0.21 | 1.16±0.14 | 1.2±0.18 | 1.13±0.19 | 0.415 |
| PINP (ng/mL) | 39.22±8.6 | 53.08±15.45 | 65.61±25.09 | 78.3±31.6 | 81.5±26.77 | 67.02±31.87 | <0.001 |
| β-CTX (ng/mL) | 0.53±0.23 | 0.68±0.25 | 0.85±0.46 | 0.8±0.4 | 1.1±0.4 | 0.9±0.33 | 0.002 |
| ALP (U/L) | 100.73±25.37 | 97±19.96 | 122.53±28.07 | 132.17±40.5 | 123.2±36.05 | 100.4±18.39 | 0.002 |
| Osteocalcin (ng/mL) | 11.82±4.5 | 18.72±7.91 | 19.71±8.03 | 20.75±10.01 | 22.21±9.26 | 30.51±25.5 | 0.015 |
Concentrations of N-terminal propeptide of type I collagen (PINP), β-isomerized C-terminal telopeptide (β-CTX), Alkaline phosphatase (ALP), calcium, phosphorus and osteocalcin are indicated as mean±standard deviation (SD).
Clinical demographics in patients with severe vertebral fractures classified according to fracture staging.
| Demographics | Stage I | Stage II | Stage III | Stage IV | Stage V | Stage VI |
|---|---|---|---|---|---|---|
| Number | 20 | 23 | 23 | 16 | 15 | 16 |
| Women | 4 | 6 | 6 | 4 | 4 | 1 |
| Men | 16 | 17 | 17 | 12 | 11 | 15 |
| Sex ratio (Male/Female) | 1:4 | 6:17 | 6:17 | 1:3 | 4:11 | 1:15 |
| Age (years) | 79.1±8.6 | 81.3±9.6 | 83.2±9.1 | 77.5±6.9 | 77.5±6.1 | 79.6±7.6 |
| Weight (kg) | 61.1±5.1 | 50.5±9.7 | 50.1±8.9 | 61.5±1.5 | 59.5±4.5 | 49.6±5 |
| Height (cm) | 159.1±6.7 | 151.1±9.6 | 150.5±9.1 | 155.9±5 | 160.1±4.5 | 150.5±6.7 |
Age, weight, and height of patients are indicated as mean±standard deviation (SD).